Local application of drugs to sympathetic nerve terminals: an electrophysiological analysis of the role of prejunctional alpha-adrenoceptors in the guinea-pig vas deferens.
1. Focal extracellular recording techniques were used to study the effects of clonidine, yohimbine and tyramine on the intermittent transmitter release mechanism in the guinea-pig vas deferens in vitro. Drugs were applied locally to the varicosities located within the recording electrode. Statistical methods were used to determine whether noradrenaline (NA) acts locally to inhibit secretion from the same or a closely related release site (local regulation) on an impulse-to-impulse basis. 2. The alpha-adrenoceptor agonist, clonidine, inhibited transmitter release, an effect reversed by the alpha-adrenoceptor antagonist, yohimbine. Yohimbine alone increased action potential-evoked transmitter release, findings consistent with the idea that transmitter release is regulated through prejunctional alpha-adrenoceptors. 3. The indirectly acting sympathomimetic, tyramine, powerfully inhibited evoked transmitter release, an effect reversed by both yohimbine and phentolamine. The inhibitory effects of tyramine were greatly reduced in tissues taken from animals pretreated with reserpine. Clonidine powerfully inhibited transmitter release in reserpinized tissues showing that prejunctional alpha-adrenoceptors were functionally intact. The inhibitory effects of tyramine on transmitter release are therefore mediated indirectly through the release of endogenous NA. 4. Paradoxically, when transmitter release from a small population of variscosities on a single nerve fibre was studied in the absence of alpha-adrenoceptor antagonists, no evidence was found for local regulation of transmitter release. 5. The intermittent character of the transmitter release process makes it difficult to envisage how impulse-to-impulse regulation could occur. Furthermore, it is unlikely that NA will accumulate to any appreciable extent in the vicinity of the secreting varicosity. 6. The pharmacological evidence clearly supports the view that NA released from sympathetic nerve terminals by nerve impulses modulates subsequent transmitter release. However, the evidence does not support the view that released NA acts locally to inhibit secretion from recently activated varicosities.
University Department of Pharmacology, Oxford.
J A
JA
Brock
T C
TC
Cunnane
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D003000:Clonidine / Q000494:pharmacology; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008297:Male; D018377:Neurotransmitter Agents / Q000378:metabolism; D011942:Receptors, Adrenergic, alpha / Q000502:physiology*; D013564:Sympathetic Nervous System / Q000187:drug effects* / Q000502:physiology; D014439:Tyramine / Q000494:pharmacology; D014649:Vas Deferens / Q000294:innervation / Q000502:physiology*; D015016:Yohimbine / Q000494:pharmacology
D018377:Neurotransmitter Agents; D011942:Receptors, Adrenergic, alpha; D015016:Yohimbine; D000255:Adenosine Triphosphate; D003000:Clonidine; D014439:Tyramine